Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286005587> ?p ?o ?g. }
- W4286005587 endingPage "130" @default.
- W4286005587 startingPage "123" @default.
- W4286005587 abstract "To understand community seroprevalence of SARS-CoV-2 in children and adolescents. This is vital to understanding the susceptibility of this cohort to COVID-19 and to inform public health policy for disease control such as immunisation.We conducted a community-based cross-sectional seroprevalence study in participants aged 0-18 years old recruiting from seven regions in England between October 2019 and June 2021 and collecting extensive demographic and symptom data. Serum samples were tested for antibodies against SARS-CoV-2 spike and nucleocapsid proteins using Roche assays processed at UK Health Security Agency laboratories. Prevalence estimates were calculated for six time periods and were standardised by age group, ethnicity and National Health Service region.Post-first wave (June-August 2020), the (anti-spike IgG) adjusted seroprevalence was 5.2%, varying from 0.9% (participants 10-14 years old) to 9.5% (participants 5-9 years old). By April-June 2021, this had increased to 19.9%, varying from 13.9% (participants 0-4 years old) to 32.7% (participants 15-18 years old). Minority ethnic groups had higher risk of SARS-CoV-2 seropositivity than white participants (OR 1.4, 95% CI 1.0 to 2.0), after adjusting for sex, age, region, time period, deprivation and urban/rural geography. In children <10 years, there were no symptoms or symptom clusters that reliably predicted seropositivity. Overall, 48% of seropositive participants with complete questionnaire data recalled no symptoms between February 2020 and their study visit.Approximately one-third of participants aged 15-18 years old had evidence of antibodies against SARS-CoV-2 prior to the introduction of widespread vaccination. These data demonstrate that ethnic background is independently associated with risk of SARS-CoV-2 infection in children.NCT04061382." @default.
- W4286005587 created "2022-07-21" @default.
- W4286005587 creator A5001121212 @default.
- W4286005587 creator A5005433406 @default.
- W4286005587 creator A5008021864 @default.
- W4286005587 creator A5008173791 @default.
- W4286005587 creator A5015357500 @default.
- W4286005587 creator A5015855291 @default.
- W4286005587 creator A5019128728 @default.
- W4286005587 creator A5025008078 @default.
- W4286005587 creator A5025446183 @default.
- W4286005587 creator A5030914420 @default.
- W4286005587 creator A5033361429 @default.
- W4286005587 creator A5038691513 @default.
- W4286005587 creator A5038939804 @default.
- W4286005587 creator A5045518355 @default.
- W4286005587 creator A5051333290 @default.
- W4286005587 creator A5053121427 @default.
- W4286005587 creator A5056192826 @default.
- W4286005587 creator A5062517303 @default.
- W4286005587 creator A5062573949 @default.
- W4286005587 creator A5065434292 @default.
- W4286005587 creator A5067773219 @default.
- W4286005587 creator A5072485453 @default.
- W4286005587 creator A5073745658 @default.
- W4286005587 creator A5074209633 @default.
- W4286005587 creator A5079603079 @default.
- W4286005587 creator A5080591768 @default.
- W4286005587 creator A5082847955 @default.
- W4286005587 creator A5084827744 @default.
- W4286005587 creator A5085665804 @default.
- W4286005587 creator A5090052569 @default.
- W4286005587 date "2022-07-20" @default.
- W4286005587 modified "2023-10-14" @default.
- W4286005587 title "Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021" @default.
- W4286005587 cites W1878724724 @default.
- W4286005587 cites W2775121321 @default.
- W4286005587 cites W3080990644 @default.
- W4286005587 cites W3094478619 @default.
- W4286005587 cites W3103185583 @default.
- W4286005587 cites W3105248716 @default.
- W4286005587 cites W3111440965 @default.
- W4286005587 cites W3128397309 @default.
- W4286005587 cites W3130587258 @default.
- W4286005587 cites W3138326401 @default.
- W4286005587 cites W3138493212 @default.
- W4286005587 cites W3210936292 @default.
- W4286005587 cites W4206775675 @default.
- W4286005587 doi "https://doi.org/10.1136/archdischild-2022-324375" @default.
- W4286005587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35858775" @default.
- W4286005587 hasPublicationYear "2022" @default.
- W4286005587 type Work @default.
- W4286005587 citedByCount "5" @default.
- W4286005587 countsByYear W42860055872023 @default.
- W4286005587 crossrefType "journal-article" @default.
- W4286005587 hasAuthorship W4286005587A5001121212 @default.
- W4286005587 hasAuthorship W4286005587A5005433406 @default.
- W4286005587 hasAuthorship W4286005587A5008021864 @default.
- W4286005587 hasAuthorship W4286005587A5008173791 @default.
- W4286005587 hasAuthorship W4286005587A5015357500 @default.
- W4286005587 hasAuthorship W4286005587A5015855291 @default.
- W4286005587 hasAuthorship W4286005587A5019128728 @default.
- W4286005587 hasAuthorship W4286005587A5025008078 @default.
- W4286005587 hasAuthorship W4286005587A5025446183 @default.
- W4286005587 hasAuthorship W4286005587A5030914420 @default.
- W4286005587 hasAuthorship W4286005587A5033361429 @default.
- W4286005587 hasAuthorship W4286005587A5038691513 @default.
- W4286005587 hasAuthorship W4286005587A5038939804 @default.
- W4286005587 hasAuthorship W4286005587A5045518355 @default.
- W4286005587 hasAuthorship W4286005587A5051333290 @default.
- W4286005587 hasAuthorship W4286005587A5053121427 @default.
- W4286005587 hasAuthorship W4286005587A5056192826 @default.
- W4286005587 hasAuthorship W4286005587A5062517303 @default.
- W4286005587 hasAuthorship W4286005587A5062573949 @default.
- W4286005587 hasAuthorship W4286005587A5065434292 @default.
- W4286005587 hasAuthorship W4286005587A5067773219 @default.
- W4286005587 hasAuthorship W4286005587A5072485453 @default.
- W4286005587 hasAuthorship W4286005587A5073745658 @default.
- W4286005587 hasAuthorship W4286005587A5074209633 @default.
- W4286005587 hasAuthorship W4286005587A5079603079 @default.
- W4286005587 hasAuthorship W4286005587A5080591768 @default.
- W4286005587 hasAuthorship W4286005587A5082847955 @default.
- W4286005587 hasAuthorship W4286005587A5084827744 @default.
- W4286005587 hasAuthorship W4286005587A5085665804 @default.
- W4286005587 hasAuthorship W4286005587A5090052569 @default.
- W4286005587 hasBestOaLocation W42860055871 @default.
- W4286005587 hasConcept C107130276 @default.
- W4286005587 hasConcept C126322002 @default.
- W4286005587 hasConcept C137403100 @default.
- W4286005587 hasConcept C138816342 @default.
- W4286005587 hasConcept C142052008 @default.
- W4286005587 hasConcept C142724271 @default.
- W4286005587 hasConcept C144024400 @default.
- W4286005587 hasConcept C149923435 @default.
- W4286005587 hasConcept C159110408 @default.
- W4286005587 hasConcept C159654299 @default.
- W4286005587 hasConcept C187212893 @default.
- W4286005587 hasConcept C19165224 @default.